STOCK TITAN

[8-K] Applied DNA Sciences, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Karpus Management, Inc. filed Amendment No. 2 to Schedule 13G for Eureka Acquisition Corp (EURKU) covering the event date 30 June 2025.

The registered investment adviser now reports beneficial ownership of 327,400 common shares, representing 4.28 % of the outstanding class. Karpus holds sole voting and dispositive power over the entire position and no shared power with other parties. Because the stake has fallen below the 5 % threshold, Karpus is no longer deemed a 5 % beneficial owner under Section 13(d) of the Exchange Act but remains subject to Rule 13d-1(b) reporting requirements.

The shares are held in discretionary advisory accounts managed by Karpus, which operates independently of its parent, City of London Investment Group plc, through established informational barriers. The filing affirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.

Implications for investors: the reduction slightly increases EURKU’s public float and removes Karpus from the list of significant 5 % holders, potentially diminishing expectations of activist involvement. Nonetheless, a 4.28 % position remains a meaningful minority interest that could provide ongoing institutional oversight.

Karpus Management, Inc. ha presentato l'Emendamento n. 2 al Modulo 13G per Eureka Acquisition Corp (EURKU) relativo alla data dell'evento del 30 giugno 2025.

Il consulente d'investimento registrato segnala ora la proprietà effettiva di 327.400 azioni ordinarie, pari al 4,28% della classe in circolazione. Karpus detiene il pieno potere di voto e di disposizione sull'intera posizione e nessun potere condiviso con altre parti. Poiché la quota è scesa sotto la soglia del 5%, Karpus non è più considerato un detentore effettivo del 5% ai sensi della Sezione 13(d) dell'Exchange Act, ma rimane soggetto agli obblighi di segnalazione della Regola 13d-1(b).

Le azioni sono detenute in conti discrezionali di consulenza gestiti da Karpus, che opera in modo indipendente dalla sua società madre, City of London Investment Group plc, attraverso barriere informative stabilite. La dichiarazione conferma che i titoli sono stati acquisiti nell'ordinaria attività commerciale e non con l'intento di influenzare il controllo dell'emittente.

Implicazioni per gli investitori: la riduzione aumenta leggermente il flottante pubblico di EURKU e rimuove Karpus dalla lista dei detentori significativi del 5%, riducendo potenzialmente le aspettative di un coinvolgimento attivista. Tuttavia, una posizione del 4,28% rimane un interesse di minoranza significativo che potrebbe garantire una supervisione istituzionale continua.

Karpus Management, Inc. presentó la Enmienda No. 2 al Anexo 13G para Eureka Acquisition Corp (EURKU) correspondiente a la fecha del evento 30 de junio de 2025.

El asesor de inversiones registrado reporta ahora la propiedad beneficiaria de 327,400 acciones comunes, que representan el 4.28% de la clase en circulación. Karpus tiene el poder exclusivo de voto y disposición sobre toda la posición y ningún poder compartido con otras partes. Debido a que la participación ha caído por debajo del umbral del 5%, Karpus ya no se considera un propietario beneficiario del 5% según la Sección 13(d) de la Ley de Intercambio, pero sigue sujeto a los requisitos de reporte de la Regla 13d-1(b).

Las acciones se mantienen en cuentas discrecionales de asesoría gestionadas por Karpus, que opera de manera independiente de su matriz, City of London Investment Group plc, mediante barreras informativas establecidas. La presentación confirma que los valores fueron adquiridos en el curso ordinario del negocio y no con el propósito de influir en el control del emisor.

Implicaciones para los inversores: la reducción incrementa ligeramente el flotante público de EURKU y elimina a Karpus de la lista de tenedores significativos del 5%, lo que podría disminuir las expectativas de participación activista. No obstante, una posición del 4.28% sigue siendo un interés minoritario significativo que podría proporcionar supervisión institucional continua.

Karpus Management, Inc.는 2025년 6월 30일 기준 Eureka Acquisition Corp (EURKU)에 대한 스케줄 13G 수정안 2호를 제출했습니다.

등록된 투자 자문사는 이제 327,400주 보통주에 대한 실질 소유권을 보고하며, 이는 발행 주식의 4.28%에 해당합니다. Karpus는 전체 보유 주식에 대해 단독 의결권 및 처분권을 가지고 있으며, 다른 당사자와 공동 권한은 없습니다. 지분이 5% 기준선 아래로 떨어짐에 따라 Karpus는 더 이상 증권거래법 섹션 13(d)에 따른 5% 실질 소유자로 간주되지 않지만, 규칙 13d-1(b)에 따른 보고 의무는 계속 유지됩니다.

주식은 Karpus가 관리하는 재량 자문 계좌에 보유되어 있으며, Karpus는 모회사인 City of London Investment Group plc와는 확립된 정보 차단 장치를 통해 독립적으로 운영됩니다. 제출 서류는 해당 증권이 통상적인 사업 과정에서 취득되었으며 발행사의 지배권에 영향을 미치기 위한 목적이 아님을 확인합니다.

투자자에 대한 시사점: 이번 감소로 EURKU의 공개 유통 주식 수가 다소 증가하고 Karpus는 5% 이상 주요 보유자 명단에서 제외되어 행동주의 개입에 대한 기대가 줄어들 수 있습니다. 그럼에도 불구하고 4.28%의 지분은 계속해서 의미 있는 소수 지분으로 남아 기관의 지속적인 감시 역할을 할 수 있습니다.

Karpus Management, Inc. a déposé l'Amendement n° 2 au Schedule 13G concernant Eureka Acquisition Corp (EURKU) pour la date de l'événement du 30 juin 2025.

Le conseiller en investissement enregistré déclare désormais une possession effective de 327 400 actions ordinaires, représentant 4,28 % de la catégorie en circulation. Karpus détient le pouvoir exclusif de vote et de disposition sur l'intégralité de la position et aucun pouvoir partagé avec d'autres parties. Étant donné que la participation est tombée en dessous du seuil de 5 %, Karpus n'est plus considéré comme un détenteur effectif de 5 % en vertu de la section 13(d) du Exchange Act, mais reste soumis aux obligations de déclaration de la règle 13d-1(b).

Les actions sont détenues dans des comptes de conseil discrétionnaires gérés par Karpus, qui opère de manière indépendante de sa société mère, City of London Investment Group plc, grâce à des barrières informationnelles établies. Le dépôt confirme que les titres ont été acquis dans le cours normal des affaires et non dans le but d'influencer le contrôle de l'émetteur.

Implications pour les investisseurs : cette réduction augmente légèrement le flottant public d’EURKU et retire Karpus de la liste des détenteurs significatifs de 5 %, ce qui pourrait diminuer les attentes d’une implication activiste. Néanmoins, une position de 4,28 % reste une participation minoritaire significative pouvant assurer une surveillance institutionnelle continue.

Karpus Management, Inc. hat die Änderung Nr. 2 zum Schedule 13G für Eureka Acquisition Corp (EURKU) mit dem Ereignisdatum 30. Juni 2025 eingereicht.

Der registrierte Investmentberater meldet nun wirtschaftliches Eigentum an 327.400 Stammaktien, was 4,28 % der ausstehenden Aktienklasse entspricht. Karpus hält alleinige Stimm- und Verfügungsgewalt über die gesamte Position und keine geteilte Macht mit anderen Parteien. Da der Anteil unter die 5 %-Schwelle gefallen ist, gilt Karpus nicht mehr als 5 %-wirtschaftlicher Eigentümer gemäß Abschnitt 13(d) des Exchange Act, unterliegt jedoch weiterhin den Meldepflichten gemäß Regel 13d-1(b).

Die Aktien werden in diskretionären Beratungskonten gehalten, die von Karpus verwaltet werden, welches unabhängig von seiner Muttergesellschaft City of London Investment Group plc durch etablierte Informationsbarrieren operiert. Die Einreichung bestätigt, dass die Wertpapiere im normalen Geschäftsverlauf erworben wurden und nicht mit dem Ziel, die Kontrolle über den Emittenten zu beeinflussen.

Auswirkungen für Investoren: Die Reduzierung erhöht leicht den Streubesitz von EURKU und entfernt Karpus von der Liste der bedeutenden 5 %-Eigentümer, was die Erwartungen an ein aktivistisches Engagement möglicherweise verringert. Dennoch bleibt eine Position von 4,28 % eine bedeutende Minderheitsbeteiligung, die eine fortlaufende institutionelle Aufsicht ermöglichen könnte.

Positive
  • Enhanced transparency: Updated 13G/A provides investors with clear, timely data on institutional ownership.
Negative
  • Stake falls below 5 %: Karpus’ reduction removes a significant holder, hinting at recent sales and slightly diluting concentrated ownership.

Insights

TL;DR – Karpus drops to 4.28 %, exiting 5 % holder status; governance impact modest.

The amendment shows Karpus’ stake now sits below the critical 5 % reporting threshold, signalling recent selling. While this reduces the probability of an activist campaign, Karpus retains sole voting control over a still-material block that can influence routine matters. The certification that shares are held in the ordinary course, plus independent control from its parent CLIG, further limits governance implications. Overall, the filing is more administrative than strategic but worth noting for ownership-structure tracking.

TL;DR – Slightly negative signal: institutional holder trims position, float rises.

For a SPAC like EURKU, concentrated holdings can support price stability. Karpus’ reduction to 4.28 % adds incremental liquidity but may introduce mild selling pressure if the exit continues. Absence of intent to influence control suggests no near-term catalyst from this shareholder. Market impact should be limited unless further divestiture emerges.

Karpus Management, Inc. ha presentato l'Emendamento n. 2 al Modulo 13G per Eureka Acquisition Corp (EURKU) relativo alla data dell'evento del 30 giugno 2025.

Il consulente d'investimento registrato segnala ora la proprietà effettiva di 327.400 azioni ordinarie, pari al 4,28% della classe in circolazione. Karpus detiene il pieno potere di voto e di disposizione sull'intera posizione e nessun potere condiviso con altre parti. Poiché la quota è scesa sotto la soglia del 5%, Karpus non è più considerato un detentore effettivo del 5% ai sensi della Sezione 13(d) dell'Exchange Act, ma rimane soggetto agli obblighi di segnalazione della Regola 13d-1(b).

Le azioni sono detenute in conti discrezionali di consulenza gestiti da Karpus, che opera in modo indipendente dalla sua società madre, City of London Investment Group plc, attraverso barriere informative stabilite. La dichiarazione conferma che i titoli sono stati acquisiti nell'ordinaria attività commerciale e non con l'intento di influenzare il controllo dell'emittente.

Implicazioni per gli investitori: la riduzione aumenta leggermente il flottante pubblico di EURKU e rimuove Karpus dalla lista dei detentori significativi del 5%, riducendo potenzialmente le aspettative di un coinvolgimento attivista. Tuttavia, una posizione del 4,28% rimane un interesse di minoranza significativo che potrebbe garantire una supervisione istituzionale continua.

Karpus Management, Inc. presentó la Enmienda No. 2 al Anexo 13G para Eureka Acquisition Corp (EURKU) correspondiente a la fecha del evento 30 de junio de 2025.

El asesor de inversiones registrado reporta ahora la propiedad beneficiaria de 327,400 acciones comunes, que representan el 4.28% de la clase en circulación. Karpus tiene el poder exclusivo de voto y disposición sobre toda la posición y ningún poder compartido con otras partes. Debido a que la participación ha caído por debajo del umbral del 5%, Karpus ya no se considera un propietario beneficiario del 5% según la Sección 13(d) de la Ley de Intercambio, pero sigue sujeto a los requisitos de reporte de la Regla 13d-1(b).

Las acciones se mantienen en cuentas discrecionales de asesoría gestionadas por Karpus, que opera de manera independiente de su matriz, City of London Investment Group plc, mediante barreras informativas establecidas. La presentación confirma que los valores fueron adquiridos en el curso ordinario del negocio y no con el propósito de influir en el control del emisor.

Implicaciones para los inversores: la reducción incrementa ligeramente el flotante público de EURKU y elimina a Karpus de la lista de tenedores significativos del 5%, lo que podría disminuir las expectativas de participación activista. No obstante, una posición del 4.28% sigue siendo un interés minoritario significativo que podría proporcionar supervisión institucional continua.

Karpus Management, Inc.는 2025년 6월 30일 기준 Eureka Acquisition Corp (EURKU)에 대한 스케줄 13G 수정안 2호를 제출했습니다.

등록된 투자 자문사는 이제 327,400주 보통주에 대한 실질 소유권을 보고하며, 이는 발행 주식의 4.28%에 해당합니다. Karpus는 전체 보유 주식에 대해 단독 의결권 및 처분권을 가지고 있으며, 다른 당사자와 공동 권한은 없습니다. 지분이 5% 기준선 아래로 떨어짐에 따라 Karpus는 더 이상 증권거래법 섹션 13(d)에 따른 5% 실질 소유자로 간주되지 않지만, 규칙 13d-1(b)에 따른 보고 의무는 계속 유지됩니다.

주식은 Karpus가 관리하는 재량 자문 계좌에 보유되어 있으며, Karpus는 모회사인 City of London Investment Group plc와는 확립된 정보 차단 장치를 통해 독립적으로 운영됩니다. 제출 서류는 해당 증권이 통상적인 사업 과정에서 취득되었으며 발행사의 지배권에 영향을 미치기 위한 목적이 아님을 확인합니다.

투자자에 대한 시사점: 이번 감소로 EURKU의 공개 유통 주식 수가 다소 증가하고 Karpus는 5% 이상 주요 보유자 명단에서 제외되어 행동주의 개입에 대한 기대가 줄어들 수 있습니다. 그럼에도 불구하고 4.28%의 지분은 계속해서 의미 있는 소수 지분으로 남아 기관의 지속적인 감시 역할을 할 수 있습니다.

Karpus Management, Inc. a déposé l'Amendement n° 2 au Schedule 13G concernant Eureka Acquisition Corp (EURKU) pour la date de l'événement du 30 juin 2025.

Le conseiller en investissement enregistré déclare désormais une possession effective de 327 400 actions ordinaires, représentant 4,28 % de la catégorie en circulation. Karpus détient le pouvoir exclusif de vote et de disposition sur l'intégralité de la position et aucun pouvoir partagé avec d'autres parties. Étant donné que la participation est tombée en dessous du seuil de 5 %, Karpus n'est plus considéré comme un détenteur effectif de 5 % en vertu de la section 13(d) du Exchange Act, mais reste soumis aux obligations de déclaration de la règle 13d-1(b).

Les actions sont détenues dans des comptes de conseil discrétionnaires gérés par Karpus, qui opère de manière indépendante de sa société mère, City of London Investment Group plc, grâce à des barrières informationnelles établies. Le dépôt confirme que les titres ont été acquis dans le cours normal des affaires et non dans le but d'influencer le contrôle de l'émetteur.

Implications pour les investisseurs : cette réduction augmente légèrement le flottant public d’EURKU et retire Karpus de la liste des détenteurs significatifs de 5 %, ce qui pourrait diminuer les attentes d’une implication activiste. Néanmoins, une position de 4,28 % reste une participation minoritaire significative pouvant assurer une surveillance institutionnelle continue.

Karpus Management, Inc. hat die Änderung Nr. 2 zum Schedule 13G für Eureka Acquisition Corp (EURKU) mit dem Ereignisdatum 30. Juni 2025 eingereicht.

Der registrierte Investmentberater meldet nun wirtschaftliches Eigentum an 327.400 Stammaktien, was 4,28 % der ausstehenden Aktienklasse entspricht. Karpus hält alleinige Stimm- und Verfügungsgewalt über die gesamte Position und keine geteilte Macht mit anderen Parteien. Da der Anteil unter die 5 %-Schwelle gefallen ist, gilt Karpus nicht mehr als 5 %-wirtschaftlicher Eigentümer gemäß Abschnitt 13(d) des Exchange Act, unterliegt jedoch weiterhin den Meldepflichten gemäß Regel 13d-1(b).

Die Aktien werden in diskretionären Beratungskonten gehalten, die von Karpus verwaltet werden, welches unabhängig von seiner Muttergesellschaft City of London Investment Group plc durch etablierte Informationsbarrieren operiert. Die Einreichung bestätigt, dass die Wertpapiere im normalen Geschäftsverlauf erworben wurden und nicht mit dem Ziel, die Kontrolle über den Emittenten zu beeinflussen.

Auswirkungen für Investoren: Die Reduzierung erhöht leicht den Streubesitz von EURKU und entfernt Karpus von der Liste der bedeutenden 5 %-Eigentümer, was die Erwartungen an ein aktivistisches Engagement möglicherweise verringert. Dennoch bleibt eine Position von 4,28 % eine bedeutende Minderheitsbeteiligung, die eine fortlaufende institutionelle Aufsicht ermöglichen könnte.

false 0000744452 0000744452 2025-07-02 2025-07-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 2, 2025

  

Applied DNA Sciences, Inc.

(Exact name of registrant as specified in its charter)

  

Delaware

(State or other jurisdiction

of incorporation)

001-36745

(Commission File Number)

59-2262718

(IRS Employer

Identification No.)

 

50 Health Sciences Drive

Stony Brook, New York 11790

(Address of principal executive offices; zip code)

  

Registrant’s telephone number, including area code:  

631-240-8800

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   APDN   The Nasdaq Stock Market

  

 

 

 

 

 

Item 8.01 Other Events.

 

On July 2, 2025, Applied DNA Sciences, Inc. (the “Company”) received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share, and that the Company is therefore in compliance with the Nasdaq Capital Market’s listing requirements. Nasdaq also notified the Company in the Compliance Notice that the hearing before the Nasdaq Hearings Panel previously scheduled to take place on July 15, 2025 has been cancelled and the Company’s securities will continue to be listed and traded on Nasdaq.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: July 7, 2025 APPLIED DNA SCIENCES, INC.
     
  By: /s/ Judith Murrah
  Name: Judith Murrah
  Title: Chief Executive Officer

 

 

FAQ

How many Eureka Acquisition Corp (EURKU) shares does Karpus Management own?

Karpus reports beneficial ownership of 327,400 common shares.

What percentage of EURKU’s outstanding shares does this represent?

The stake equals 4.28 % of the outstanding common stock.

Does Karpus share voting or dispositive power over these shares?

No. The adviser holds sole voting and dispositive power and reports 0 % shared power.

Under which SEC rule is the Schedule 13G/A filed?

The filing is made pursuant to Rule 13d-1(b) for registered investment advisers.

What is the significance of falling below the 5 % ownership threshold?

Below 5 %, Karpus is no longer a statutory 5 % holder, reducing regulatory obligations and potential influence on control matters.
Applied Dna Scie

NASDAQ:APDN

APDN Rankings

APDN Latest News

APDN Latest SEC Filings

APDN Stock Data

2.40M
418.86k
19.47%
26.9%
5.44%
Diagnostics & Research
Services-testing Laboratories
Link
United States
STONY BROOK